Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Regulatory News (TYR)

  • There is currently no data for TYR

Appointment

17 Mar 2008 07:02

TyraTech, Inc.17 March 2008 For immediate release 17 March 2008 TyraTech Inc. ("TyraTech" or "the Company") TyraTech Appoints Sr. Director Business Development Kim Watson to Expand Global Partnerships for Clean Pesticide and Animal Health Company TyraTech Inc (AIM: TYR), a pioneer of safer, effective and natural activeingredients for the pesticide, animal health and human functional food markets,announces today the appointment of Kim Watson as Senior Director BusinessDevelopment. Watson will identify new commercial development partnerships andmarket opportunities to expand TyraTech's traction in the internationalinstitutional, agricultural, consumer, and animal and public health markets. Inthe newly created position, Watson will report to Stephen Briggs, Vice PresidentGlobal Markets. "TyraTech's growing line of active ingredient components for extremelyeffective products for the entire invertebrate pest control spectrum haspositioned the Company for numerous commercial opportunities. In order tocapitalise on the breadth and strength of our proprietary technology, we arecurrently pursuing an aggressive growth strategy of major industry partnershipsand licensing," said R. Douglas Armstrong, Ph.D., CEO of TyraTech. "Aninvaluable addition to our team, Watson brings specific experience in realisingboth new market opportunities as well as paths to market through industrycollaboration and partnership." Watson has more than 20 years of experience in discovering, developing andcommercialising new technologies in the agricultural chemical industry. Prior tojoining TyraTech, Watson served as director of product acquisitions andlicensing at FMC Corporation, a worldwide, diversified chemical companyheadquartered in Philadelphia. While at FMC, he was responsible for driving newbusiness growth through acquisitions or licensing and secured exclusive accessto several platform technologies. He also spent several years working withBayer Australia, where he was a technical development officer and responsiblefor the marketing and distribution of proprietary agricultural chemicals. Watsonis an active member in industry associations, including the Licensing ExecutivesSociety, and holds 18 technology patents of his own. Steve Briggs added, "The Company has seen a material increase in commercial anddevelopment capability following recent key appointments, which havecomplemented our already strong research and technology development resources".The addition of Mr. Watson complements other recent commercial market teamadditions at TyraTech which have included Dr. Peter Porpiglia, joining TyraTechfrom Kumiai Chemical as Sr. Director Product Development, and William Baxter,who moved from BASF as Sr. Director Market Development. For further information please contact: TyraTech Inc. +1 (321) 409 7403Douglas Armstrong PhD, Chief Executive Officerwww.tyratech.com Buchanan Communications +44 (0) 20 7466 5000Mary-Jane Johnson) / Lisa Baderoon / Catherine Breenwww.buchanan.uk.com About TyraTech, Inc. TyraTech is pioneering a new class of highly effective, non-toxic, pesticidesand anti-parasitic compounds to address global agriculture, horticulture,functional foods, healthcare and veterinary markets. Using a revolutionarychemoreceptor screening process, TyraTech has identified proprietary blends ofnatural oils that stimulate the reactions and biological behaviour of insectsand parasites so that they can be effectively repelled or killed. TyraTech'stechnology avoids the environmental concerns and human health risks as well asthe development of resistance that are both associated with chemical pesticides,while still providing highly potent efficacy. The Company's products have been validated through strong partnerships withmultinational conglomerates operating within a growing US$23 billion worldwidemarket that is being increasingly driven by environmental legislation andend-user demand. TyraTech continues to develop new product applications based on safe, naturalingredients with a broad range of partners around the world. www.tyratech.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Nov 20185:25 pmRNSTyratech
2nd Nov 20185:30 pmRNSTyratech
31st Oct 20183:01 pmRNSResult of Special Meeting, Cancellation from AIM
25th Oct 20187:00 amRNSSpecial Meeting and Acquisition Update
18th Oct 20183:00 pmRNSNominee accounts
9th Oct 20182:23 pmRNSPosting of Proxy Statement and Timetable Update
5th Oct 201810:05 amRNSUpdate
28th Sep 20188:50 amRNSInterim Results
28th Sep 20187:00 amRNSConditional Merger Agreement Signed with AMVAC
23rd May 20187:00 amRNSFinal Results
9th May 20187:00 amRNSProgress in 2018 on products and milestones
3rd May 20187:00 amRNSChange of Adviser
24th Jan 20185:44 pmRNSHolding(s) in Company
18th Jan 20187:00 amRNSHolding(s) in Company
15th Jan 20187:00 amRNSResult of Tender Offer
11th Jan 20181:08 pmRNSTR-1
9th Jan 20185:01 pmRNSTR-1
5th Jan 20187:00 amRNSResult of Tender Offer
28th Dec 20177:00 amRNSResult of Special Meeting
4th Dec 20177:00 amRNSTender Offer to Shareholders and Notice of Meeting
12th Sep 20177:00 amRNSInterim Results for Six Months Ended 30 June 2017
24th Aug 20177:00 amRNSCOMPANY UPDATE AND DATE OF INTERIM RESULTS
4th Jul 20172:29 pmRNSJoint Development and License Agreement
29th Jun 20177:00 amRNSResult of AGM
7th Jun 20177:00 amRNSTYR TR-1: Notification of major interest in shares
9th May 20177:00 amRNSResults for the Year Ended 31 December 2016
28th Apr 20173:24 pmRNSFurther re Notice of Final Results
22nd Mar 20178:57 amRNSTR-1: Notification of major interest in shares
9th Feb 20177:00 amRNSPre-close Trading Update
19th Sep 20163:59 pmRNSDirector/PDMR Shareholding
15th Sep 20161:18 pmRNSDirectors' Dealings
13th Sep 20167:00 amRNSInterim Results for Six Months Ended 30 June 2016
28th Jul 20167:00 amRNSPre Close Trading Update
8th Jun 20163:22 pmRNSResult of AGM and Board Change
22nd Apr 20161:57 pmRNSDirectors' Dealings
15th Apr 201612:03 pmRNSAward of Share Options
15th Apr 201611:57 amRNSDirectors' Dealings
14th Apr 20167:00 amRNSDirectors' Dealings
11th Apr 20167:00 amRNSAppointment of José Barella as Chairman
4th Apr 20167:00 amRNSNotice of Preliminary Results
3rd Feb 201612:31 pmRNSHolding(s) in Company
1st Feb 20161:08 pmRNSDirector's Dealings
1st Feb 20167:00 amRNSPre-close Trading Update
20th Jan 20167:00 amRNSAppointment of Erica H. Boisvert as CFO
13th Jan 20167:00 amRNSNew Product Range Launch & Distribution Agreement
17th Dec 20154:01 pmRNSTR-1: Notification of Major Interest in Shares
4th Dec 201511:00 amRNSTR-1: Notification of major interest in shares
26th Nov 201512:51 pmRNSTR-1: Notification of Major Interest in Shares
16th Nov 20155:01 pmRNSResult of Special Meeting & Director Shareholdings
4th Nov 20157:00 amRNSPlacing and Subscription to raise £3.16m

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.